Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
US7579450B2 · kind B2 · utility
3Cited by
51References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2005 |
| Grant date | Aug 25, 2009 |
| Priority date | — |
| Expiry date | Apr 27, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/351
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.